Undesirable effects and cosmetovigilance after product launch
How to receive, assess, document and report undesirable and serious undesirable effects associated with cosmetic products in the EU.
Read the guide →Labelling and marketing communication must be truthful, supportable and consistent with the PIF and safety assessment. We review the complete presentation before print and publication.
Regulatory review of labels, INCI lists, mandatory particulars and substantiation for cosmetic claims on packaging, websites and advertising.
The exact scope is confirmed after reviewing the product, target markets and available documentation.
Not necessarily. The level and type of evidence depend on the claim, the product and the reasonable expectations of the average end user.
Yes. Claims are assessed regardless of whether they appear on packaging, websites, social media or promotional material.
Yes. The entire presentation is assessed, including the name, imagery and context.
How to receive, assess, document and report undesirable and serious undesirable effects associated with cosmetic products in the EU.
Read the guide →What Regulation (EU) 2023/1545 changes for fragrance allergen labelling, which thresholds apply and how to prepare formulas and labels for 2026 and 2028.
Read the guide →How to plan reformulation after an ingredient restriction and align testing, CPSR, PIF, labelling, CPNP and packaging stocks.
Read the guide →Send us the essential product details, target markets and available documentation. We will respond by email.